Luigetti, Marco https://orcid.org/0000-0001-7539-505X
Vitali, Francesca
Romano, Angela
Sciarrone, Maria Ausilia
Guglielmino, Valeria
Ardito, Michelangelo
Sabino, Andrea
Servidei, Serenella
Piro, Geny
Carbone, Carmine
Graziani, Francesca
Lillo, Rosa
Ferraro, Pietro Manuel
Primiano, Guido
Article History
Received: 15 March 2024
Accepted: 31 July 2024
First Online: 7 August 2024
Competing interests
: M. Luigetti received financial grants (honoraria and speaking) from Ackea, Alnylam, Sobi, and Pfizer and travel grants from Ackea, Alnylam, Sobi, Pfizer, Kedrion, and Grifols. A. Romano received financial grants (honoraria and speaking) from Akcea and travel grants from Akcea, Alnylam, Pfizer, and Csl Behring. P. M. Ferraro received grants/consultant fees from Allena Pharmaceuticals, Alnylam, Amgen, AstraZeneca, BioHealth Italia, Gilead, Otsuka Pharmaceuticals, and Vifor Fresenius. Guido Primiano received financial grants (honoraria and speaking) from Sanofi. The other authors have no conflicts of interest to disclose.